Article
Robust clinical detection of SARS-CoV-2 variants by RT-PCR/MALDI-TOF multi-target approach
2021-09-16
Abstract excerpt
The COVID-19 pandemic sparked rapid development of SARS-CoV-2 diagnostics. However, emerging variants pose the risk for target dropout and false-negative results secondary to primer/probe binding site (PBS) mismatches. The Agena MassARRAY ® SARS-CoV-2 Panel combines RT-PCR and MALDI-TOF mass-spectrometry to probe for five targets across N and ORF1ab genes, which provides a robust platform to accommodate PBS mismat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- faaaf3a7-ef18-502c-8880-6cecbd08c015
- DOI
- 10.1101/2021.09.09.21263348
